文献速递妇科

良性指征子宫切除术后阿片类药物处方模式、患者使用及术后疼痛

Opioid Prescribing Patterns, Patient Use, and Postoperative Pain After Hysterectomy for Benign Indications.
PubMed 文献 · Obstet Gynecol · 2017-01-01

在一所大学医院开展的前瞻性质量改进研究中,102例因良性非产科指征行子宫切除术的患者纳入分析,术后2周内医生开具的阿片类药物中位量为200口服吗啡当量,患者约使用一半,中位剩余110吗啡当量;术前纤维肌痛调查评分等可预测阿片类药物消耗量。

要点

  • 子宫切除术后患者使用的阿片类药物约为处方量的一半,中位剩余110口服吗啡当量。
  • 术前纤维肌痛调查评分最高三分位与每日阿片类药物消耗量较高相关。
  • 作者认为应考虑对术后疼痛的阿片类药物处方采取个体化方法。

核心结论

  • 大型学术医疗中心的妇科医生开具的阿片类药物量约为患者子宫切除术后平均使用量的两倍。
  • 作者认为应考虑对术后疼痛的阿片类药物处方采取个体化方法。

研究设计与样本

  • 前瞻性质量改进研究,于2015年8月至2015年12月在一所大学医院招募所有因良性非产科指征行子宫切除术的英语患者,排除有重大医疗疾病或物质滥用者。
  • 103例符合条件患者中102例(99%)同意参与,包括44例(43.1%)腹腔镜、42例(41.2%)阴道和16例(15.7%)经腹子宫切除术。
  • 89例(87%)参与者完成电话调查,60例(59%)参与者返回日记。
  • 术前患者完成纤维肌痛调查,术后通过每日日记和术后14天结构化电话访谈收集阿片类药物使用量(转换为口服吗啡当量)和疼痛评分(0-10数字评定量表)。

主要发现

  • 开具的阿片类药物中位量为200口服吗啡当量(四分位距150-250)。
  • 患者报告使用了约一半处方阿片类药物,中位剩余110吗啡当量(四分位距40-150)。
  • 总阿片类药物消耗量的最佳拟合模型识别出术前纤维肌痛调查评分、整体身体疼痛、术前阿片类药物使用、既往子宫内膜异位症、经腹子宫切除术(与腹腔镜相比)和子宫重量为显著预测因素。
  • 纤维肌痛调查评分最高三分位与每日阿片类药物消耗量较高相关(基线时口服吗啡当量多13.9 [95% CI 3.0-24.8],P=.02)。
  • 日记未应答者与应答者基线特征不同。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 日记未应答者与应答者基线特征不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify physician prescribing patterns and patient opioid use in the 2 weeks after hysterectomy at an academic institution and to determine whether patient factors predict postsurgical opioid use and pain recovery. METHODS: We conducted a prospective quality initiative study by recruiting all English-speaking patients undergoing hysterectomy for benign, nonobstetric indications at a university hospital between August 2015 and December 2015, excluding those with major medical morbidities or substance abuse. Before hysterectomy, patients completed the Fibromyalgia Survey, a validated measure of centralized pain. After hysterectomy, opioid use (converted to oral morphine equivalents) and pain scores (0-10 numeric rating scale) were collected by a daily diary and a structured telephone interview 14 days after surgery. Primary outcomes were total opioid prescribed and consumed in the 2 weeks after hysterectomy. Secondary outcomes included daily opioid use and daily pain severity for 14 days after hysterectomy. RESULTS: Of 103 eligible patients, 102 (99%) agreed to participate, including 44 (43.1%) laparoscopic, 42 (41.2%) vaginal, and 16 (15.7%) abdominal hysterectomies. Telephone surveys were completed on 89 (87%) participants; diaries were returned from 60 (59%) participants. Diary nonresponders had different baseline characteristics than nonresponders. Median amount of opioid prescribed was 200 oral morphine equivalents (interquartile range 150-250). Patients reported using approximately half of the opioids prescribed with a median excess of 110 morphine equivalents (interquartile range 40-150). The best fit model of total opioid consumption identified preoperative Fibromyalgia Survey Score, overall body pain, preoperative opioid use, prior endometriosis, abdominal hysterectomy (compared with laparoscopic), and uterine weight as significant predictors. Highest tertile of Fibromyalgia Survey Score was associated with greater daily opioid consumption (13.9 [95% CI 3.0-24.8] greater oral morphine equivalents at baseline, P=.02). CONCLUSION: Gynecologists at a large academic medical center prescribe twice the amount of opioids than the average patient uses after hysterectomy. A personalized approach to prescribing opioids for postoperative pain should be considered.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. As-Sanie S, Till SR, Mowers EL, et al. Opioid Prescribing Patterns, Patient Use, and Postoperative Pain After Hysterectomy for Benign Indications. Obstet Gynecol. 2017. PMID: 29112660. doi:10.1097/AOG.0000000000002344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。